StockNews.com started coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research report report published on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Stock Performance Corbus Pharmaceuticals stock opened at $5.25 on Friday. Corbus Pharmaceuticals has a 52 week low of $2.11 and a […]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) saw a large drop in short interest in November. As of November 30th, there was short interest totalling 45,500 shares, a drop of 19.8% from the November 15th total of 56,700 shares. Approximately 1.0% of the company’s stock are short sold. Based on an average daily […]
Investment analysts at StockNews.com assumed coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report) in a research note issued on Sunday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Stock Performance NASDAQ:CRBP opened at $5.50 on Friday. The stock has a fifty day moving average price of $5.20 […]
StockNews.com began coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Stock Performance Shares of NASDAQ CRBP opened at $5.55 on Friday. The company has a market cap of $24.53 million, a PE ratio […]
StockNews.com began coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a report released on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Oppenheimer reiterated an outperform rating and issued a $22.00 price target on shares of Corbus Pharmaceuticals in a research note on Wednesday, August 9th. […]